Imprivata, the healthcare IT security company, today launched Imprivata Confirm ID™, a comprehensive product that will enable a major shift from paper to electronic prescribing of controlled substances (EPCS).
Imprivata Confirm ID Overview
Imprivata Confirm ID simplifies adoption of regulatory requirements for EPCS, helping care providers address the workflow inefficiencies and potential for fraud caused by paper-based prescriptions. The solution creates a secure chain of trust by simplifying
Read More
EPCS
E-Prescribing Controlled Substances: The Time is NOW!
Written by Irene Froehlich, Director of Marketing at DrFirst The healthcare industry has been talking about the benefits of e-prescribing for years. By now, the advantages offered to your practice and your patients—through increased workflow efficiency and reduced medication errors—are obvious. However,making e-prescribing for controlled substances (EPCS) available to physicians has proven to be more of a challenge. This has frustrated providers, patients, and loved ones of patients alike.
Read More
